189 related articles for article (PubMed ID: 24065161)
1. Influence of lipid A acylation pattern on membrane permeability and innate immune stimulation.
Li Y; Wang Z; Chen J; Ernst RK; Wang X
Mar Drugs; 2013 Aug; 11(9):3197-208. PubMed ID: 24065161
[TBL] [Abstract][Full Text] [Related]
2. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
Rossi O; Pesce I; Giannelli C; Aprea S; Caboni M; Citiulo F; Valentini S; Ferlenghi I; MacLennan CA; D'Oro U; Saul A; Gerke C
J Biol Chem; 2014 Sep; 289(36):24922-35. PubMed ID: 25023285
[TBL] [Abstract][Full Text] [Related]
3. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.
Rallabhandi P; Awomoyi A; Thomas KE; Phalipon A; Fujimoto Y; Fukase K; Kusumoto S; Qureshi N; Sztein MB; Vogel SN
J Immunol; 2008 Jan; 180(2):1139-47. PubMed ID: 18178854
[TBL] [Abstract][Full Text] [Related]
5. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
[TBL] [Abstract][Full Text] [Related]
6. Position-Specific Secondary Acylation Determines Detection of Lipid A by Murine TLR4 and Caspase-11.
Harberts EM; Grubaugh D; Akuma DC; Shin S; Ernst RK; Brodsky IE
Infect Immun; 2022 Aug; 90(8):e0020122. PubMed ID: 35862717
[TBL] [Abstract][Full Text] [Related]
7. Lipid A Variants Activate Human TLR4 and the Noncanonical Inflammasome Differently and Require the Core Oligosaccharide for Inflammasome Activation.
Alexander-Floyd J; Bass AR; Harberts EM; Grubaugh D; Buxbaum JD; Brodsky IE; Ernst RK; Shin S
Infect Immun; 2022 Aug; 90(8):e0020822. PubMed ID: 35862709
[TBL] [Abstract][Full Text] [Related]
8. Evasion of human innate immunity without antagonizing TLR4 by mutant Salmonella enterica serovar Typhimurium having penta-acylated lipid A.
Matsuura M; Kawasaki K; Kawahara K; Mitsuyama M
Innate Immun; 2012 Oct; 18(5):764-73. PubMed ID: 22419537
[TBL] [Abstract][Full Text] [Related]
9. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
[TBL] [Abstract][Full Text] [Related]
10. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
11. From agonist to antagonist: structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins.
DeMarco ML; Woods RJ
Mol Immunol; 2011 Oct; 49(1-2):124-33. PubMed ID: 21924775
[TBL] [Abstract][Full Text] [Related]
12. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature.
Kawahara K; Tsukano H; Watanabe H; Lindner B; Matsuura M
Infect Immun; 2002 Aug; 70(8):4092-8. PubMed ID: 12117916
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A.
Stead CM; Beasley A; Cotter RJ; Trent MS
J Bacteriol; 2008 Nov; 190(21):7012-21. PubMed ID: 18757539
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid A structure and TLR4-dependent innate immune activation.
Sengyee S; Yoon SH; Paksanont S; Yimthin T; Wuthiekanun V; Limmathurotsakul D; West TE; Ernst RK; Chantratita N
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006287. PubMed ID: 29474381
[TBL] [Abstract][Full Text] [Related]
15. Characterization of complex, heterogeneous lipid A samples using HPLC-MS/MS technique I. Overall analysis with respect to acylation, phosphorylation and isobaric distribution.
Sándor V; Dörnyei Á; Makszin L; Kilár F; Péterfi Z; Kocsis B; Kilár A
J Mass Spectrom; 2016 Nov; 51(11):1043-1063. PubMed ID: 27506631
[TBL] [Abstract][Full Text] [Related]
16. The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.
Manterola L; Moriyón I; Moreno E; Sola-Landa A; Weiss DS; Koch MH; Howe J; Brandenburg K; López-Goñi I
J Bacteriol; 2005 Aug; 187(16):5631-9. PubMed ID: 16077108
[TBL] [Abstract][Full Text] [Related]
17. The LpxL acyltransferase is required for normal growth and penta-acylation of lipid A in Burkholderia cenocepacia.
Fathy Mohamed Y; Hamad M; Ortega XP; Valvano MA
Mol Microbiol; 2017 Apr; 104(1):144-162. PubMed ID: 28085228
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Yersinia enterocolitica strains increase the outer membrane permeability in response to environmental stimuli by modulating lipopolysaccharide fluidity and lipid A structure.
Bengoechea JA; Brandenburg K; Arraiza MD; Seydel U; Skurnik M; Moriyón I
Infect Immun; 2003 Apr; 71(4):2014-21. PubMed ID: 12654821
[TBL] [Abstract][Full Text] [Related]
19. Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis.
Novem V; Shui G; Wang D; Bendt AK; Sim SH; Liu Y; Thong TW; Sivalingam SP; Ooi EE; Wenk MR; Tan G
Clin Vaccine Immunol; 2009 Oct; 16(10):1420-8. PubMed ID: 19692625
[TBL] [Abstract][Full Text] [Related]
20. Structural variants of Salmonella Typhimurium lipopolysaccharide induce less dimerization of TLR4/MD-2 and reduced pro-inflammatory cytokine production in human monocytes.
Aldapa-Vega G; Moreno-Eutimio MA; Berlanga-Taylor AJ; Jiménez-Uribe AP; Nieto-Velazquez G; López-Ortega O; Mancilla-Herrera I; Cortés-Malagón EM; Gunn JS; Isibasi A; Wong-Baeza I; López-Macías C; Pastelin-Palacios R
Mol Immunol; 2019 Jul; 111():43-52. PubMed ID: 30959420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
